Monday, February 05, 2018 1:56:47 PM
B07 Immunologic activation in recurrent high-grade glioma patients with durable complete response
following treatment with Toca 511 and Toca FC. Clark Chen, University of Minnesota, Minneapolis, MN.
B08 Toca 511 and Toca FC: Durable complete responses observed in patients with IDH1 wild-type
and mutant recurrent high-grade glioma (rHGG). Bob Carter, Massachusetts General Hospital, Boston,
MA
http://www.aacr.org/Documents/CNS_Poster%20Session%20B_website.pdf
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM